priority review designation in tgct, bla submitted in her2 breast cancer, and more
Published 5 years ago • 203 plays • Length 11:38
Download video MP4
Download video MP3
Similar videos
-
11:00
fda approval in her2 breast cancer, priority review in nsclc, and more
-
10:55
fda approvals in cinv and her2 breast cancer, priority review in myelofibrosis, and more
-
11:13
fda approval in her2 early breast cancer, fast track designation in tnbc, and more
-
12:17
fda approvals in breast cancer and prostate cancer, priority review in breast cancer, and more
-
7:28
fda approvals in pml, nsclc, and breast cancer, priority review in dlbcl, and more
-
9:29
fda approvals in all and breast cancer, priority reviews in cml and follicular lymphoma, and more
-
10:46
fda approval in all, priority reviews in cml and breast cancer, and more
-
10:49
fda approvals in melanoma and breast cancer, and priority reviews in prostate cancer and more
-
9:37
fda approvals in nhl and cinv, priority reviews in melanoma and breast cancer, and more
-
7:19
fda approval in hcc, priority reviews in tnbc and ovarian cancer, snda in itp, and more
-
9:27
fda approval in bladder cancer, breakthrough therapy designation in dlbcl, and more
-
11:32
fda approvals in breast cancer and nsclc, nda accepted in hcc, and more
-
12:33
priority review in squamous nsclc, european recommendations across tumor types, and more
-
7:18
full fda approvals in breast cancer and lung cancer, priority reviews in all, and more
-
4:27
study of immunotherapy combinations for patients with her2-positive metastatic breast cancer
-
7:21
fda approval in breast cancer, breakthrough designations in aml and bladder cancer, and more
-
0:31
preview: priority reviews in breast cancer and nsclc, promising results in ovarian cancer, and more
-
8:59
guidelines and approaches to her2 testing for breast cancer
-
7:11
review on 2016 fda approvals, halt on aml trials, and more
Clip.africa.com - Privacy-policy